Followers | 21 |
Posts | 475 |
Boards Moderated | 0 |
Alias Born | 01/22/2013 |
Tuesday, November 04, 2014 11:21:47 AM
classic short tactic here and everyone that has done their dd knows it
plus add in the political moves by the pharm mfgs that stand to lose a ton to this new technology
IBIO has technology that is far beyond the ebola bubble, just so happened that the ebola buzz has put the spotlight on this and helped to position IBIO for license/buyout of their intellectual property method for advanced med production with lower capital requirements and accelerated time to market along with drastically increased production volume capabilities... (see their website for specifics)
this is why it is a good fit for ebola too since the current method is costly, time consuming and extremely low annual dose creation.
ebola aside, this company is about to explode in cash
Recent IBIO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 09:27:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:06:21 PM
- iBio Reports Fiscal First Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/12/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2024 01:12:33 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 10/10/2024 08:16:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/10/2024 08:10:53 PM
- iBio and AstralBio Provide Update on Myostatin Program for Obesity • GlobeNewswire Inc. • 10/10/2024 12:00:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 09/24/2024 08:11:53 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/20/2024 08:14:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:07:16 PM
- iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 09/20/2024 08:05:00 PM
- iBio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 09/03/2024 11:00:00 AM
- iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development • GlobeNewswire Inc. • 08/12/2024 08:30:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/06/2024 09:02:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 01:03:41 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/25/2024 09:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:02:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:10:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:08:04 PM
- iBio Closes Sale of Manufacturing Facility in Texas • GlobeNewswire Inc. • 06/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 10:55:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:32:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:30:55 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM